Intec Pharma LTD announced the appointment of Roger J. Pomerantz M.D., F.A.C.P. to its board of directors. Dr. Pomerantz is President, Chief Executive Officer and Chairman of the Board of Directors of Seres Therapeutics Inc. with this appointment the company's board has seven directors including six whom are independent. Prior to joining Seres Dr. Pomerantz was worldwide head of licensing & acquisitions, senior vice president at Merck & Co. Inc., where he oversaw all licensing and acquisitions at Merck Research Laboratories including external research, out-licensing regional deals and academic alliances. Previously he served as senior vice president and Global Franchise Head of infectious diseases at Merck. Prior to joining Merck Dr. Pomerantz was global head of infectious diseases for Johnson & Johnson pharmaceuticals where he was responsible for all anti-infective agents worldwide.